148 related articles for article (PubMed ID: 3350852)
1. Natural killer cell activities of patients with breast cancer against different target cells.
Hamilton G; Reiner A; Teleky B; Roth E; Kolb R; Spona J; Jakesz R
J Cancer Res Clin Oncol; 1988; 114(2):191-6. PubMed ID: 3350852
[TBL] [Abstract][Full Text] [Related]
2. Human breast cancer and impaired NK cell function.
Garner WL; Minton JP; James AG; Hoffmann CC
J Surg Oncol; 1983 Sep; 24(1):64-6. PubMed ID: 6887939
[TBL] [Abstract][Full Text] [Related]
3. Impaired natural killer cell lysis in breast cancer patients with high levels of psychological stress is associated with altered expression of killer immunoglobin-like receptors.
Varker KA; Terrell CE; Welt M; Suleiman S; Thornton L; Andersen BL; Carson WE
J Surg Res; 2007 May; 139(1):36-44. PubMed ID: 17292412
[TBL] [Abstract][Full Text] [Related]
4. Association of increased lytic effector cell function with high estrogen receptor levels in tumor-bearing patients with breast cancer.
Zielinski CC; Tichatschek E; Müller C; Kalinowski W; Sevelda P; Czerwenka K; Kubista E; Spona J
Cancer; 1989 May; 63(10):1985-9. PubMed ID: 2702570
[TBL] [Abstract][Full Text] [Related]
5. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
6. Variable natural killer function of tumour-infiltrating lymphocytes from breast carcinomas.
Gudmundsdóttir I; Ogmundsdóttir HM
APMIS; 1992 Aug; 100(8):737-46. PubMed ID: 1325805
[TBL] [Abstract][Full Text] [Related]
7. Natural killer (NK) activity in peripheral blood lymphocytes of patients with benign and malignant breast disease.
White D; Jones DB; Cooke T; Kirkham N
Br J Cancer; 1982 Oct; 46(4):611-6. PubMed ID: 7138766
[TBL] [Abstract][Full Text] [Related]
8. Cytolysis of mammary tumor targets by resting, interleukin-2 stimulated and in vitro cultured peripheral blood lymphocytes from breast cancer patients.
Brenner BG; McCrea EL; Margolese RG
Anticancer Res; 1988; 8(4):653-8. PubMed ID: 3263077
[TBL] [Abstract][Full Text] [Related]
9. The relationship of chemotherapeutic and endocrine intervention on natural killer cell activity in human breast cancer.
Brenner BG; Margolese RG
Cancer; 1991 Aug; 68(3):482-8. PubMed ID: 2065267
[TBL] [Abstract][Full Text] [Related]
10. Ex Vivo-expanded Natural Killer Cells Derived From Long-term Cryopreserved Cord Blood are Cytotoxic Against Primary Breast Cancer Cells.
Nham T; Poznanski SM; Fan IY; Vahedi F; Shenouda MM; Lee AJ; Chew MV; Hogg RT; Lee DA; Ashkar AA
J Immunother; 2018; 41(2):64-72. PubMed ID: 29189387
[TBL] [Abstract][Full Text] [Related]
11. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
Uchida A; Klein E
Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
[TBL] [Abstract][Full Text] [Related]
12. Sera from patients with colon, breast and lung cancer induce resistance to lysis mediated by NK cytotoxic factors (NKCF).
Marubayashi M; Solana R; Ramirez R; Aranda E; Galan F; Peña J
Br J Cancer; 1991 Jun; 63(6):893-6. PubMed ID: 1906292
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of 27-kDa heat-shock protein in MCF-7 breast cancer cells: effects on lymphocyte-mediated killing by natural killer and gamma delta T cells.
Mahvi DM; Carper SW; Storm FK; Teal SR; Sondel PM
Cancer Immunol Immunother; 1993 Aug; 37(3):181-6. PubMed ID: 8334681
[TBL] [Abstract][Full Text] [Related]
14. [NK (natural killer) and K (killer) cell activity in breast cancer. Relation of the stage of the disease to cytotoxic activity].
Garam T; Bakács T; Tótpál K; Svastits E; Ringwald G; Petrányi G
Orv Hetil; 1983 Jan; 124(1):15-8. PubMed ID: 6828317
[No Abstract] [Full Text] [Related]
15. Peripheral blood lymphocytes from patients with cancer lack interleukin-2 receptors.
Hakim AA
Cancer; 1988 Feb; 61(4):689-701. PubMed ID: 2962732
[TBL] [Abstract][Full Text] [Related]
16. Relationship of natural killer cytotoxicity to clinical and biochemical parameters of primary human breast cancer.
Fulton A; Heppner G; Roi L; Howard L; Russo J; Brennan M
Breast Cancer Res Treat; 1984; 4(2):109-16. PubMed ID: 6743837
[TBL] [Abstract][Full Text] [Related]
17. [Steroid receptors and NK cell activity in patients with breast cancer].
Konjević G; Branković-Magić M; Nikolić-Vukosavljević D; Spuzić I
Srp Arh Celok Lek; 1994; 122(5-6):139-42. PubMed ID: 17977410
[TBL] [Abstract][Full Text] [Related]
18. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility.
Uchida A; Vánky F; Klein E
J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cell activity in patients with carcinoma of the larynx and hypopharynx.
Wustrow TP; Zenner HP
Laryngoscope; 1985 Nov; 95(11):1391-400. PubMed ID: 3903404
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours.
Shenouda MM; Gillgrass A; Nham T; Hogg R; Lee AJ; Chew MV; Shafaei M; Aarts C; Lee DA; Hassell J; Bane A; Dhesy-Thind S; Ashkar AA
Breast Cancer Res; 2017 Jul; 19(1):76. PubMed ID: 28668076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
